RPRX
Royalty Pharma plc
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$770.9M
↓ 10.2%
Operating Income
$1.6B
↑ 20.7%
Revenue
$2.4B
↑ 5.1%
Total Assets
$19.6B
↑ 7.7%
Total Liabilities
$9.9B
↑ 25.7%
Cash & Equivalents
$618.7M
↓ 33.4%
EPS (Diluted)
$1.78
↓ 6.8%
Long-term Debt
$9.0B
↑ 17.6%

Recent SEC Filings

Form Type Filed Date Link
13F-NT 8/14/2026 View on SEC
144 8/13/2026 View on SEC
144 8/12/2026 View on SEC
144 8/12/2026 View on SEC
4 8/7/2026 View on SEC
4 8/7/2026 View on SEC
4 8/7/2026 View on SEC
4 8/7/2026 View on SEC
10-Q 8/5/2026 View on SEC
8-K 8/5/2026 View on SEC

Company Information

Field Value
Ticker RPRX
Company Name Royalty Pharma plc
CIK 1802768
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation X0
Phone (212) 883-0200